Gerontology & Geriatrics

Ad26.RSV.preF-RSV preF protein vaccine immunogenic in seniors

An adenovirus serotype 26 respiratory syncytial virus (RSV) vector encoding a prefusion F (preF) protein (Ad26.RSV.preF) in combination with RSV preF protein is immunogenic and prevents RSV-mediated lower respiratory tract ...

Diseases, Conditions, Syndromes

Moderna reports positive results for RSV vaccine

US biotech company Moderna on Tuesday announced positive interim trial results for its vaccine against respiratory syncytial virus (RSV) in adults over the age of 60.

Diseases, Conditions, Syndromes

Researchers make gains in race to protect against RSV

As a surge in cases of respiratory syncytial virus, or RSV, continues pushing hospitals to capacity across the U.S., researchers at Georgia State's Institute for Biomedical Sciences are working to develop vaccines and other ...

Diseases, Conditions, Syndromes

COVID restrictions may have contributed to increase in RSV infections

Annual spikes in infections from the respiratory syncytial virus—or RSV—are usually so predictable that "you can set your clock" by it, says Yale School of Public Health Associate Professor of Epidemiology (Microbial ...

page 12 from 27